Respiro Diagnostics vs Transcripta Bio
Respiro Diagnostics vs Transcripta Bio, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Respiro Diagnostics is on 39/100 and Transcripta Bio on 54/100.
Where each one leads
Respiro Diagnostics
Leads on none of the measures we hold for both companies.
Transcripta Bio
- our overall score: 54/100 against 39/100
- funding raised: $24.0M against $1.0M
At a glance
| Measure | Respiro Diagnostics | Transcripta Bio |
|---|---|---|
| What it is | Developing breath-based diagnostics for lung diseases. | AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development. |
| Category | Biotechnology, Healthcare, Diagnostics, Medical Devices | Biotechnology, Artificial Intelligence, Drug Discovery, Neurology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | Not published | 2023 |
| Headquarters | Cambridge, United Kingdom | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Respiro Diagnostics | Transcripta Bio |
|---|---|---|
| Total funding | $1.0M | $24.0M |
| Latest round | Pre-Seed | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Respiro Diagnostics | Transcripta Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 54/100 |
| Traction | 30/100 | 37/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 25/100 | 17/100 |
| Quality | 48/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (49/100) |
| Domain ratingLink authority, 0-100 | Not published | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Respiro Diagnostics | Transcripta Bio |
|---|---|---|
| Frameworks | Not detected | Next.js, Tailwind CSS |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | Respiro Diagnostics | Transcripta Bio |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Transcripta Bio Wins the Genomics Category 🧬💻. Transcripta Bio took home the trophy for Genomics, and for good reason. They are bridging the gap between massive transcriptomic data and actual drug candidates.”r/AIDiscoveryAward
Respiro Diagnostics vs Transcripta Bio: common questions
Which is better, Respiro Diagnostics or Transcripta Bio?
On our 0-100 score Transcripta Bio rates higher (54/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Respiro Diagnostics and Transcripta Bio compare on the numbers?
Transcripta Bio leads on our overall score (54/100 against 39/100), funding raised ($24.0M against $1.0M).
What do real users say about Respiro Diagnostics and Transcripta Bio?
Transcripta Bio: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/AIDiscoveryAward.
Read the full Respiro Diagnostics review and pricing or the Transcripta Bio review and pricing. You can also browse other Respiro Diagnostics alternatives we track.